Cargando…

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome

Oxidative stress seems to be present in patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the correlation between characteristics of PCOS and serum concentrations of afamin, a novel binding protein for the antioxidant vitamin E. A total of 85 patients with PCOS an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köninger, Angela, Edimiris, Philippos, Koch, Laura, Enekwe, Antje, Lamina, Claudia, Kasimir-Bauer, Sabine, Kimmig, Rainer, Dieplinger, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073231/ https://www.ncbi.nlm.nih.gov/pubmed/24928911 http://dx.doi.org/10.1530/EC-14-0053

Ejemplares similares

Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018)

Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
por: Köninger, Angela, et al.
Publicado: (2019)

Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
por: Seeber, Beata, et al.
Publicado: (2014)

Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
por: Köninger, Angela, et al.
Publicado: (2018)

Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment
por: Bredemeier, Maren, et al.
Publicado: (2016)

The vitamin E-binding protein afamin increases in maternal serum during pregnancy
por: Hubalek, Michael, et al.
Publicado: (2014)

Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer
por: Bredemeier, Maren, et al.
Publicado: (2017)

Anti-Mullerian-hormone levels during pregnancy and postpartum
por: Köninger, Angela, et al.
Publicado: (2013)

Serum Afamin a Novel Marker of Increased Hepatic Lipid Content
por: Kurdiova, Timea, et al.
Publicado: (2021)

Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma()
por: Dieplinger, Benjamin, et al.
Publicado: (2013)

The vitamin E–binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis
por: Seeber, Beata E., et al.
Publicado: (2010)

Assessment of Serum Concentrations of Adropin, Afamin, and Neudesin in Children with Type 1 Diabetes
por: Polkowska, Agnieszka, et al.
Publicado: (2019)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
por: Keup, Corinna, et al.
Publicado: (2023)

Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer Patients
por: Mach, Pawel, et al.
Publicado: (2021)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2022)

Evaluation of first- and third-trimester afamin levels in preeclampsia
por: Gülücü, Selim, et al.
Publicado: (2023)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients
por: Keup, Corinna, et al.
Publicado: (2021)

Evaluation of Afamin Level after Bariatric Surgery in Patient with Obesity
por: Demircioglu, Hilmi, et al.
Publicado: (2023)

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
por: Chen, Shenghui, et al.
Publicado: (2022)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
por: Kuhlmann, Jan Dominik, et al.
Publicado: (2012)

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients
por: Bittner, Ann‐Kathrin, et al.
Publicado: (2020)

Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

The N14 anti-afamin antibody Fab: a rare V(L)1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling
por: Naschberger, Andreas, et al.
Publicado: (2016)

Prevalence of Elevated Glycated Hemoglobin Concentrations in the Polycystic Ovary Syndrome: Anthropometrical and Metabolic Relationship in Amazonian Women
por: de Medeiros, Sebastiao Freitas, et al.
Publicado: (2014)

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2009)

Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
por: Chebouti, Issam, et al.
Publicado: (2016)

Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer
por: Buderath, Paul, et al.
Publicado: (2016)

Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
por: Peng, Yuanyuan, et al.
Publicado: (2022)

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2016)

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
por: Chebouti, Issam, et al.
Publicado: (2017)

Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
por: Buderath, Paul, et al.
Publicado: (2019)

Fetal subdural hematoma, sickle cell disease and storage pool disease: A case report
por: Iannaccone, Antonella, et al.
Publicado: (2020)

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients
por: Hoffmann, Oliver, et al.
Publicado: (2023)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0s7vcd8cse4qk4ru71rmsn7ge0